{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:38:08Z","timestamp":1758040688190,"version":"3.44.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1067\/mob.2000.107434","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:19:27Z","timestamp":1027556367000},"page":"1623-1628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Minimal precycle testing and ongoing cycle monitoring for in vitro fertilization and fresh pre-embryo transfer do not compromise fertilization, implantation, or ongoing pregnancy rates"],"prefix":"10.1067","volume":"182","author":[{"suffix":"Jr","given":"Estil Y.","family":"Strawn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Roesler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Rinke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.James","family":"Aiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mob.2000.107434_bib1","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0015-0282(99)00139-9","article-title":"Impact of the \"physician factor\" on pregnancy rates in a large assisted reproductive technology program: do too many cooks spoil the broth?","volume":"71","author":"Karande","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1067\/mob.2000.107434_bib2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00060793-199512000-00005","article-title":"The endocrinology of the assisted reproductive technologies","volume":"2","author":"Damario","year":"1995","journal-title":"Curr Opin Endocrinol Diabetes"},{"key":"10.1067\/mob.2000.107434_bib3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/00003495-199652030-00002","article-title":"In vitro fertilisation:a review of drug therapy and clinical management","volume":"52","author":"Jennings","year":"1996","journal-title":"Drugs"},{"key":"10.1067\/mob.2000.107434_bib4","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0015-0282(16)54652-4","article-title":"Is it possible to run a successful ovulation induction program based solely on ultrasound monitoring? The importance of endometrial measurements","volume":"56","author":"Shoham","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1067\/mob.2000.107434_bib5","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/oxfordjournals.humrep.a138724","article-title":"Simplification of IVF: minimal monitoring and the use of subcutaneous highly purified FSH administration for ovulation induction","volume":"98","author":"Wikland","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1067\/mob.2000.107434_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0015-0282(16)54187-9","article-title":"Follicular monitoring and outcome of in vitro fertilization in gonadotropin-releasing hormone-agonist treated cycles","volume":"55","author":"Forman","year":"1991","journal-title":"Fertil Steril"},{"year":"1998","series-title":"Induction of ovarian follicle development and ovulation with exogenous gonadotropins","key":"10.1067\/mob.2000.107434_bib7"},{"year":"1998","series-title":"Guidelines for gamete and embryo donation. Guidelines and minimum standards","key":"10.1067\/mob.2000.107434_bib8"},{"key":"10.1067\/mob.2000.107434_bib9","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0015-0282(98)00046-6","article-title":"Characteristics of consecutive in vitro fertilization cycles among patients treated with follicle-stimulating hormone (FSH) and human menopausal gonadotropin versus FSH alone","volume":"69","author":"Sills","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1067\/mob.2000.107434_bib10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0015-0282(16)56946-5","article-title":"Sperm morphology as diagnosed by strict criteria: probing the impact of teratozoospermia on fertilization rate and pregnancy outcome in a large in vitro fertilization population","volume":"62","author":"Grow","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1067\/mob.2000.107434_bib11","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0015-0282(16)49891-2","article-title":"Sperm morphologic features as a prognostic factor in in vitro fertilization","volume":"46","author":"Kruger","year":"1986","journal-title":"Fertil Steril"},{"key":"10.1067\/mob.2000.107434_bib12","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0015-0282(98)00034-X","article-title":"Validity and cost-effectiveness of antisperm antibody testing before in vitro fertilization","volume":"69","author":"Culligan","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1067\/mob.2000.107434_bib13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1600-0897.1993.tb00611.x","article-title":"Relationship of sperm antibodies in women and men to human in vitro fertilization, cleavage, and pregnancy rate","volume":"30","author":"Chang","year":"1993","journal-title":"Am J Reprod Immunol"},{"issue":"9","key":"10.1067\/mob.2000.107434_bib14","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/humrep\/14.9.2230","article-title":"A prospective randomized comparison of ovulation induction using highly purified follicle stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization","volume":"14","author":"Sills","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1067\/mob.2000.107434_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/09513599809024964","article-title":"Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization","volume":"12","author":"Agrawal","year":"1998","journal-title":"Gynecol Endocrinol"},{"key":"10.1067\/mob.2000.107434_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF02766827","article-title":"Comparison of highly purified FSH (metrodin-high purity) with pergonal for IVF superovulation","volume":"15","author":"Bagratee","year":"1998","journal-title":"J Assist Reprod Genet"},{"key":"10.1067\/mob.2000.107434_bib17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/HUMREP\/11.3.474","article-title":"Controlled ovarian stimulation using highly purified FSH results in a lower serum oestradiol profile in the follicular phase as compared with HMG","volume":"11","author":"Fried","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1067\/mob.2000.107434_bib18","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0015-0282(98)00010-7","article-title":"The performance of subcutaneously injected Fertinex when used as the sole gonadotropin for in vitro fertilization stimulation","volume":"69","author":"Miller","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1067\/mob.2000.107434_bib19","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/oxfordjournals.humrep.a136151","article-title":"Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotropin-releasing hormone antagonist-treated monkeys","volume":"10","author":"Zelinski-Wooten","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1067\/mob.2000.107434_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/humupd\/3.2.101","article-title":"Follicular development and oocyte maturation in hypogonadotrophic women employing recombinant follicle-stimulating hormone: the role of oestradiol","volume":"3","author":"Fauser","year":"1997","journal-title":"Hum Reprod Update"},{"key":"10.1067\/mob.2000.107434_bib21","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0015-0282(16)53945-4","article-title":"Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropinreleasing hormone agonist suppression are not predictive of pregnancy outcome","volume":"54","author":"Edelstein","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1067\/mob.2000.107434_bib22","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0015-0282(16)57066-6","article-title":"Elevated serum levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles","volume":"62","author":"Givens","year":"1994","journal-title":"Fertil Steril"},{"year":"1998","series-title":"1996 Assisted Reproductive Technology Success Rates, National Summary and Fertility Clinic Reports","key":"10.1067\/mob.2000.107434_bib23"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937800005500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937800005500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:40:29Z","timestamp":1757583629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937800005500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["S0002937800005500"],"URL":"https:\/\/doi.org\/10.1067\/mob.2000.107434","relation":{},"ISSN":["0002-9378"],"issn-type":[{"type":"print","value":"0002-9378"}],"subject":[],"published":{"date-parts":[[2000,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimal precycle testing and ongoing cycle monitoring for in vitro fertilization and fresh pre-embryo transfer do not compromise fertilization, implantation, or ongoing pregnancy rates","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/mob.2000.107434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}